Cleared Traditional

Butterfly iQ/iQ+ Ultrasound System (K220068) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2023
Decision
445d
Days
Class 2
Risk

K220068 is an FDA 510(k) clearance for the Butterfly iQ/iQ+ Ultrasound System. Classified as System, Imaging, Pulsed Echo, Ultrasonic (product code IYO), Class II - Special Controls.

Submitted by Butterfly Network, Inc. (Guildford, US). The FDA issued a Cleared decision on March 31, 2023 after a review of 445 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1560 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Radiology submissions.

View all Butterfly Network, Inc. devices

Submission Details

510(k) Number K220068 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 10, 2022
Decision Date March 31, 2023
Days to Decision 445 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
338d slower than avg
Panel avg: 107d · This submission: 445d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IYO System, Imaging, Pulsed Echo, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYO System, Imaging, Pulsed Echo, Ultrasonic

All 212
Devices cleared under the same product code (IYO) and FDA review panel - the closest regulatory comparables to K220068.
SiteRite™ 9 Ultrasound System
K231283 · Bard Access Systems, Inc. (C.R. Bard, Inc.) · Sep 2023
Bladder Scanner Model: BVT02
K223448 · Xuzhou Kaixin Electronic Instrument Co., Ltd. · Jul 2023
Velacur
K223287 · Sonic Incytes · Apr 2023
FibroScan® device (Models: 502 Touch, 530 Compact, 430 Mini+, 230, and 630)
K223902 · Echosens · Mar 2023
Sunkingdom Ophthalmic Ultrasound Examination Instrument SK-3000A, SK-3000B, SK-3000C, SK-2000AP, SK-2000A, SK-2000P
K222787 · Chongqing Sunkingdom Medical Instrument Co., Ltd. · Jan 2023
QT Scanner 2000 Model A
K220933 · Qt Imaging, Inc. · Aug 2022